Search Results
Managing TKI Therapy in CML
Efficacy & tolerability of available TKI therapies in CML & managing TKI resistance
Understanding the cause of TKI resistance to improve management strategies in CML
Managing cardiovascular risks associated with lifelong TKI therapy in CML
How to Treat Chronic Myeloid Leukemia (CML) - Dr. Jorge Cortes
Managing Toxicities from BCR-ABL TKIs in CML
Case 1: TKI Therapy and Sequencing Decisions in CP-CML
Chronic Myeloid Leukemia (CML) - Treatment - Tyrosine Kinase (TK) Inhibitors
Managing Toxicities from Chronic Myeloid Leukemia Treatment
Outcomes of patients with CML with no molecular response within two years of TKI therapy
Case 1: TKI Therapy in CP-CML
Management of chronic myeloid leukemia: an update
